Posts Tagged ‘OHSU Knight Cancer Institute’

A new study, published in the New England Journal of Medicine, found that 63 percent of multiple myeloma patients have a reduced risk of disease progression or death if treated with lenalidomide (Revlimid®) following a stem cell transplant. The study was co-authored by Richard Mariarz, MD, medical director of the Adult Stem Cell Transplantation Program & Center for Hematologic Malignancies at the Knight Cancer Institute. Read the OHSU News Release to learn more.

The Knight Cancer Institute invites you to attend its latest talk featuring distinguished scientist and Nobel Laureate Elizabeth Blackburn, Ph.D., a Morris Herztein Endowed Professor in Biology and Physiology University of California, San Francisco, Department of Biochemistry and Biophysics. Dr. Blackburn will be discussing “Telomeres and their maintenance machinery: Ramifications for cells and organisms.” This seminar will take place at 4:00 p.m. on Tuesday, April 17 in the Old Library Auditorium. About Dr. Blackburn Dr. Blackburn is … Read More

The 2012 BioMedicine in 4D Symposium, hosted by OHSU’s Center for Spatial Systems Biomedicine, will be held March 21 – 23 in the OHSU Old Library. Keynote speakers include Brian Druker, M.D., on March 22, and Stephen Quake, D.Phil, on March 23. Sessions will explore integration of -omics with new and developing microscopy techniques, expanded role of modeling, and translation of the new approaches into therapies. The Center for Spatial Systems Biomedicine brings exciting initiatives … Read More

The V Foundation for Cancer Research Translational Awards provide up to $200,000 per year for three years to fund projects that intend to develop novel approaches to the prevention, detection and treatment of human cancer. Collaboration of investigators from both the lab and clinic is required. Project teams must have a minimum of two scientists from the same facility and the team must possess basic and clinical research expertise. One application is permitted per institution. … Read More

A list of speakers is now available for the Shared Resources Colloquium on March 21, part of the BioMedicine in 4D conference in the OHSU Old Library. From 11 a.m. to 5:30 p.m., attend presentations highlighting the OHSU Shared Resources Cores. Core directors will introduce their campus services and how they can help you get the most out of your research endeavors. Please also plan to join us at the end of the day for … Read More

Brian Druker, M.D., head of OHSU’s Knight Cancer Institute, has been awarded the prestigious 2012 Japan Prize in Healthcare and Medical Technology for pioneering the development of targeted cancer drugs. Dr. Druker shares the Japan Prize with two other scientists who have revolutionized the way we think about cancer treatment: Nicholas B. Lydon, Ph.D., founder and director of Blueprint Medicines, and Janet D. Rowley, M.D., Blum-Riese Distinguished Service Professor of Medicine, Molecular Genetics & Cell … Read More

Umpqua Bank, in conjunction with OHSU’s Knight Cancer Institute and Doernbecher Children’s Hospital is offering $10,000 grants for Innovation in Pediatric Cancer Research. The purpose of this award is to cultivate outstanding, young pediatric cancer researchers (clinical, translational or basic science) by assisting in the generation of preliminary data for peer-reviewed national funding or career development proposals. Applications are due January 20, 2012. Proposals will be accepted from OHSU faculty members within five years of … Read More

If you don’t already follow the Knight Cancer Institute’s Knight News, here’s a brief update on what OHSU cancer researchers have been to up this month. Joshi Alumkal, M.D., receives award from the Prostate Cancer Foundation Joshi Alumkal, M.D., Assistant Professor of Hematology and Oncology, was one of 24 researchers internationally to be awarded the 2011 Prostate Cancer Foundation Young Investigator Award. Dr. Alumkal’s project will focus on inhibiting LSD1 (Lysine-specific demethylase 1), a protein … Read More

David Dilts, PhD, MBA, professor in OHSU’s Division of Management and Director of Clinical Research for the Knight Cancer Institute, has been recognized by the NIH for participating in the development of AccrualNet, an online resource meant to address difficulties in clinical trial recruitment. Dr. Dilts and others at the Knight Cancer Institute hope to advance personalized cancer medicine by eliminating roadblocks in current processes for clinical research. Visit Knight News to read an interview … Read More

The OHSU Research Integrity Office is now holding monthly brown bag sessions led by the Institutional Review Board (IRB) analysts to address topics of interest to human subjects researchers. December’s brown bag session is jointly sponsored by the Knight Cancer Institute and the OHSU IRB.  Sarah Ward, Denise Mathes, and Susan Aust of the Knight Cancer Institute and Andrea Johnson of the IRB will cover the following topics: New IND/IDE management services for investigator initiated … Read More